Antiemetic Medications Market Size & Forecast

Posted 2025-07-16 09:42:00

According to FutureWise analysis, the market for Antiemetic drugs was estimated to be US$ 8.17 billion in 2023 and is expected to reach US$ 13.29 billion in 2031 at a CAGR of 6.30%.

Antiemetic medications serve an essential function in managing nausea and vomiting, which can result from various factors, including medical conditions, treatments, surgical procedures, and medications. These drugs come in multiple forms, such as tablets, sublingual tablets, oral solutions, suppositories, transdermal patches, and intravenous injections, providing options that cater to individual preferences and medical situations.

Several classes of antiemetic drugs are utilized for the effective management of these symptoms. For instance, 5-HT3 receptor antagonists, such as ondansetron, are particularly effective for conditions like acute gastroenteritis and postoperative nausea, as well as for the common side effects of radiotherapy and chemotherapy. Dopamine antagonists, including metoclopramide and domperidone, are frequently prescribed for postoperative nausea and motion sickness.

Moreover, H1 antihistamines and antimuscarinics such as scopolamine are effective in alleviating nausea and vomiting caused by vestibular disturbances. Transdermal patches provide a convenient method for the administration of these medications. Glucocorticoids are typically indicated for chemotherapy-induced vomiting, while neurokinin 1 (NK-1) receptor antagonists, such as aprepitant, represent newer options in managing symptoms associated with chemotherapy and radiotherapy.

The selection of the most suitable antiemetic medication depends on a thorough assessment conducted by a healthcare professional. This assessment takes into account the specific context, severity, and underlying cause of the symptoms. Personalized treatment is crucial, considering the individual's medical history and potential side effects.

Due to the variety of available antiemetic medications, it is important for healthcare experts to guide the selection process to ensure effective symptom relief while minimizing adverse effects. Common side effects associated with antiemetic drugs can include headache, fatigue, dizziness, dry mouth, and alterations in bowel habits. Therefore, careful selection of the appropriate antiemetic should be made in consultation with a qualified healthcare provider, reflecting the patient's unique circumstances, the severity and origin of the symptoms, as well as any coexisting medical conditions or concurrent medications.

FutureWise Market Research has published a report that provides an insightful analysis of Antiemetic Drugs Market trends that are affecting the overall market growth.

Request a Free Sample @ https://www.futurewiseresearch.com/contact.aspx?rpt=11170&type=requestsample

Antiemetic Drugs Market Segmentation:

By Type of Drug

5-HT3 receptor antagonists
Dopamine antagonists
Steroid-Corticosteroids
Benzodiazepines
NK1 receptor antagonist
Antihistamines
Cannabinoids
Anticholinergic
Others

By Application

Chemotherapy
Pregnancy
Motion Sickness
Food Poisoning
Gastroenteritis
Dizziness
General Anesthetics
Opioid Analgesics
Emotional Stress
Others

By Region

North America
Europe
Asia-Pacific
Latin America
Middle East and Africa

Competitive Landscape in Antiemetic Drugs Market:

Baxter International
Novartis AG
Johnson and Johnson
GlaxoSmithKline Plc
Cipla Ltd.
Pfizer Inc.
Astellas Pharma
Merck
Sanofi-Aventis
Abbott Labs

Buy now the latest version of this report: https://www.futurewiseresearch.com/checkout.aspx?ReportId=11170&license=multi

**Objectives of this Study: **

To provide a comprehensive analysis of the Antiemetic Drugs Market By Type of Drug, By Application and By Region.
To offer detailed insights into factors such as drivers, restraints, trends, and opportunities, as well as segmental and regional influences on market growth.
To evaluate current market trends and forecast micro-markets, presenting overall market projections in the form of data sets and PowerPoint presentations.
To predict the market size in key regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.

Flexible Delivery Model:

We have a flexible delivery model and you can suggest changes in the scope/table of contents as per your requirement
The customization services offered are free of charge with the purchase of any license of the report.
You can directly share your requirements/changes to the current table of contents to: sales@futurewiseresearch.com